Management Team
Svein
Mathisen, President and CEO
Svein has a Master of Science degree in Engineering Physics. Lives
in Malmö, Sweden. He has been President and CEO of BioInvent
since 1997 and has been a member of the Board since 2001. He
previously held a number of senior positions within the Norsk Hydro
Group. In addition to his roles at BioInvent, Svein is Chairman of
the Board of the Biotec Pharmacon ASA and a member of the Board of
the SwedenBio organisation.
Shareholding: 1,050,000
Employee options: 15,000
Björn
Frendéus, Vice President, Preclinical
Research
Björn is a Doctor of Immunology. Lives in Landskrona, Sweden.
He graduated as the nation's first student from the Swedish
Foundation for Strategic Research funded Biomedicine programs
within the Infection & Vaccinology programme in 2001. He
has worked at BioInvent since 2001.
Shareholding: 740 (own and affiliated
holdings)
Employee options: 35,250
Cristina Glad, Executive Vice
President
Cristina is a Doctor of Science in Biochemistry and has an
MBA. Lives in Malmö, Sweden. Cristina has worked at
BioInvent since 1987, starting out at the former subsidiary
BioInvent Production AB. She is a member of the Royal Swedish
Academy of Engineering Sciences.
Shareholding: 1,043,301
Employee options: 15,000
Steven Glazer, Senior Vice President,
Development
Steven is a Doctor of Medicine. Lives in Copenhagen, Denmark.
He has been employed at BioInvent since 2004. Prior to this he was
Medical Director and Director of Development at Maxygen A/S in
Denmark and before that he worked at NovoNordisk A/S.
Shareholding: -
Employee options: 37,500
Per-Anders Johansson, Vice President,
Quality Assurance and Regulatory Affairs
Per-Anders is a Master of Science in Chemistry.
Lives in Lund, Sweden. He has worked at BioInvent since 1984,
initially being employed by the former subsidiary BioInvent
Production AB.
Shareholding: 250,000
Employee options: 15,000
Martin Wiles, Senior Vice President, Business
Development
Martin has a PhD in Chemistry and an MBA. Lives in London,
Great Britain. He has worked at BioInvent since 2003. Prior to this
he spent four years as Head of Business Development at KS Biomedix
Holdings Plc, a public company listed on the London Stock
Exchange.
Shareholding: -
Employee options: 37,500